Cargando…
The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer
NF-κB activation occurs in the majority patients with pancreatic ductal adenocarcinoma (PDAC); however, directly targeting NF-κB has proven unsuccessful, and recent studies have demonstrated a certain effect of the indirect inhibition of NF-κB. Myeloid differentiation factor 88 (MyD88) is a common i...
Autores principales: | Lu, Sinan, He, Tianyu, Zhang, Yuan, Zhou, Bo, Zhang, Qiyi, Yan, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308493/ https://www.ncbi.nlm.nih.gov/pubmed/37326109 http://dx.doi.org/10.3892/or.2023.8585 |
Ejemplares similares
-
MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients
por: Ramirez-Perez, Sergio, et al.
Publicado: (2023) -
ST2825, a Small Molecule Inhibitor of MyD88, Suppresses NF-κB Activation and the ROS/NLRP3/Cleaved Caspase-1 Signaling Pathway to Attenuate Lipopolysaccharide-Stimulated Neuroinflammation
por: Zhang, Shan-Shan, et al.
Publicado: (2022) -
Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor
por: Ramírez-Pérez, Sergio, et al.
Publicado: (2020) -
Disrupting myddosome assembly in diffuse large B-cell lymphoma cells using the MYD88 dimerization inhibitor ST2825
por: Wang, Xin, et al.
Publicado: (2019) -
Lipopolysaccharide-induced NF-κB nuclear translocation is primarily dependent on MyD88, but TNFα expression requires TRIF and MyD88
por: Sakai, Jiro, et al.
Publicado: (2017)